Pharmafile Logo
Pharmafocus logo
Advanced Search

Symbicort

Showing 6 posts of 6 posts found.

astrazeneca_plaque

AstraZeneca wins US court ruling on Symbicort patent claims

March 3, 2021
Research and Development AstraZeneca, Symbicort, law

A US district court has ruled in favour of AstraZeneca in litigation against Mylan Pharmaceuticals and Kindeva Drug Delivery, AstraZeneca …

News
Breo image

GSK and Theravance see FDA nod for asthma indication

March 20, 2015
Sales and Marketing Advair, AstraZeneca, Dulera, FDA, Foradil, GSK, Merck, Symbicort, Theravance, asthma, breo, budesonide/formoterol fumarate dihydratem, ellipta, fluticasone propionate, formoterol fumarate, mometasone/formoterol

An FDA panel has recommended the approval of asthma treatment Breo Ellipta in adults – but voted against supporting its …

News

AstraZeneca secures respiratory drugs from Almirall

July 30, 2014
Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, Symbicort, lung drugs

AstraZeneca has paid $875 million to take control of Alimirall’s respiratory drug portfolio that includes treatments for bronchitis and emphysema. …

News

Europe poised for generic Symbicort

February 24, 2014
Manufacturing and Production, Sales and Marketing AstraZeneca, CHMP, COPD, Symbicort, Teva, breo, generics

The CHMP has given Teva Pharmaceutical Industries a lift by recommending that its generic version of AstraZeneca’s lung drug Symbicort …

News
screen_shot_2012-07-27_at_11

IT problems at Swedish plant affect AstraZeneca

July 27, 2012
Manufacturing and Production AstraZeneca, Nexium, Symbicort, financials

Software problems at a manufacturing facility operated by AstraZeneca in Sweden are having a material impact on the business, pegging …

News

Symbicort gains COPD indication

March 4, 2009
Research and Development Symbicort

AstraZeneca's respiratory drug Symbicort can be used to help US patients with chronic obstructive pulmonary disease (COPD). The FDA has …

News

Latest content

Gilead shares phase 3 results from HIV prevention trial

June 21, 2024

Sarepta Therapeutics gains expanded FDA approval for DMD treatment

June 21, 2024

FDA approves AbbVie’s Skyrizi for UC treatment

June 20, 2024

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024

EC grants marketing authorisation to Sobi’s Altuvoct for haemophilia A treatment

June 19, 2024